Codes / ICD10CM / D05.0

D05.0 Lobular carcinoma in situ of breast

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Lobular carcinoma in situ of breast
  • Often referred to as "LCIS" or "lobular neoplasia."

Summary

Lobular carcinoma in situ (LCIS) is a non-invasive condition where abnormal cells are found in the lobules (milk-producing glands) of the breast. It is not considered true cancer but indicates an increased risk of developing invasive breast cancer in either breast. LCIS is typically detected incidentally during a biopsy performed for another reason.

Causes

The exact cause of LCIS is not fully understood, but it involves genetic changes in the cells of the breast lobules. Hormonal factors and genetic predispositions may contribute to its development.

Risk Factors

  • Female gender, particularly premenopausal women.
  • Family history of breast cancer.
  • Genetic mutations such as those in the BRCA1 or BRCA2 genes.
  • Prior history of benign breast conditions like atypical lobular hyperplasia.

Symptoms

LCIS usually has no symptoms and is often found during a biopsy for an unrelated breast issue. Rarely, it may be associated with a lump or other breast changes, but these are not typical.

Diagnosis

LCIS is diagnosed through a breast biopsy, which may be performed after an abnormal mammogram or ultrasound. Pathological examination of the tissue confirms the presence of abnormal cells confined to the lobules.

Treatment Options

  • Active Surveillance: Regular monitoring with clinical breast exams and imaging, as LCIS is not cancer but a risk factor.
  • Risk-Reducing Medications: Hormonal therapies like tamoxifen or raloxifene may be considered to lower breast cancer risk.
  • Prophylactic Surgery: Bilateral mastectomy is an option for very high-risk individuals, though it is not routinely recommended.

Prognosis and Follow-Up

LCIS itself does not spread or become life-threatening, but it increases the risk of future invasive breast cancer. Follow-up typically includes regular breast exams and imaging, with treatment decisions based on individual risk factors.

Complications

The primary complication is the elevated risk of developing invasive breast cancer. LCIS does not typically cause physical symptoms or metastasis.

Lifestyle & Prevention

  • Maintain a healthy weight and exercise regularly.
  • Limit alcohol consumption.
  • Discuss risk-reducing strategies with a healthcare provider, especially if there is a family history of breast cancer.

When to Seek Professional Help

Consult a healthcare provider if you notice new breast changes, such as a lump, skin changes, or nipple discharge, or if you have concerns about your breast cancer risk.

Tips for Medical Coders

Document the specific breast involved (e.g., left, right, or bilateral) and any associated procedures or risk-reduction therapies. Ensure the diagnosis is clearly linked to the biopsy or imaging that led to the LCIS identification.

Book a walkthrough

D05.0 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.